Literature DB >> 3279284

Amiodarone in the management of cardiac arrhythmias: current concepts.

H H Rotmensch1, B Belhassen.   

Abstract

This article reviews current information on the clinical pharmacology, therapeutic utility, and adverse reactions of amiodarone, with emphasis on guidelines for its rational use.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3279284     DOI： 10.1016/s0025-7125(16)30773-8

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  7 in total

Review 1.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Antiarrhythmic drugs in the management of atrial fibrillation.

Authors:  J C Cowan
Journal:  Br Heart J       Date:  1993-10

Review 3.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Regulation of A1 adenosine receptors by amiodarone and electrical stimulation in rat myocardial cells in vitro.

Authors:  D El-Ani; K A Jacobson; A Shainberg
Journal:  Biochem Pharmacol       Date:  1997-09-01       Impact factor: 5.858

Review 5.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

6.  Side effects with amiodarone therapy.

Authors:  R Shukla; N I Jowett; D R Thompson; J E Pohl
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

7.  Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.

Authors:  M J Chapman; J L Moran; M S O'Fathartaigh; A R Peisach; D N Cunningham
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.